is a progressive form of dementia occurring in middle age. It is associated with
diffuse degeneration of the brain. Patients display a broad range of cognitive
impairments, behavioural symptoms, and mood changes.
As a result, they require an individualized and multimodal treatment plan that
evolves with time in order to address newly emergin issues. Doctors involved in
the care of these patients should be vigilant
for symptoms likely to be present and should help the patients and family
anticipate future symptoms
and the care likely to be required.
treatment require several approches:
Psyco-therapies and other psycosocial treatments
Specific pharmacological treatment
Treatment of cognitive symptoms (tacrine,
donezepil, vitamin E, selegiline, ergot mesylates)
press left arrow in your browser for previous page